CAMPATH Side Effects

7020065-0 | Liver Function Test Abnormal
on Sep 16, 2010 Female patient from BELGIUM , 77 years of age, weighting 191.8 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: liver function test abnormal. Campath dosage: . During the same period patient was treated with CACIT VITAMINE D3 (View Cacit Vitamine D3 Review and Cacit Vitamine D3 Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), NULYTELY (View Nulytely Review and Nulytely Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), PERIO AID MOUTHWASH (View Perio Aid Mouthwash Review and Perio Aid Mouthwash Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), LODOZ (View Lodoz Review and Lodoz Label ). Patient was hospitalized.

7014583-9 | Injection Site Pain, Injection Site Rash
Patient was taking Campath (View Usage). Patient had the following side effects: injection site pain, injection site rash on Aug 26, 2010 from UNITED STATES Additional patient health information: Male patient , 54 years of age, was diagnosed with chronic lymphocytic leukaemia and. Campath dosage: As Used: 3 Mg.

6984406-2 | Liver Function Test Abnormal
Adverse event was reported on Sep 07, 2010 by a Female patient taking Campath (View Usage) (Dosage: ) was diagnosed with chronic lymphocytic leukaemia and. Location: BELGIUM , 77 years of age, weighting 191.8 lb, After Campath was administered, patient had the following side effects: liver function test abnormal. Patient was hospitalized.

6984404-9 | Injection Site Cellulitis
on Sep 09, 2010 Female patient from UNITED STATES , 70 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: injection site cellulitis. Campath dosage: As Used: 3 Mg.


6984402-5 | Injection Site Cellulitis
on Sep 09, 2010 Female patient from UNITED STATES , 76 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath (View Usage). Patient had the following side effects: injection site cellulitis. Campath dosage: As Used: 3 Mg.

6971294-3 | Pancytopenia, Progressive Multifocal Leukoencephalopathy, Thrombocytopenia
Patient was taking Campath (View Usage). After Campath was administered, patient had the following side effects: pancytopenia, progressive multifocal leukoencephalopathy, thrombocytopenia on Sep 01, 2010 from UNITED STATES Additional patient health information: Male patient , 71 years of age, was diagnosed with chronic lymphocytic leukaemia refractory and. Campath dosage: Total Daily Dose: 30 Mg. During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ).

6970535-6 | Interstitial Lung Disease, Neutropenia, Pulmonary Alveolar Haemorrhage, Respiratory Failure
Adverse event was reported on Aug 31, 2010 by a Male patient taking Campath (View Usage) (Dosage: Total Daily Dose: 3 Mg) . Location: KOREA, REPUBLIC OF , 55 years of age, Patient experienced the following unwanted or unexpected effects: interstitial lung disease, neutropenia, pulmonary alveolar haemorrhage, respiratory failure. During the same period patient was treated with CISPLATIN (Total Daily Dose: 100 Mg/m2) (View Cisplatin Review and Cisplatin Label ), CYTARABINE (Total Daily Dose: 4000 Mg/m2) (View Cytarabine Review and Cytarabine Label ), DEXAMETHASONE (Total Daily Dose: 40 Mg) (View Dexamethasone Review and Dexamethasone Label ), CHLORPHENIRAMINE MALEATE (Before Each Alemtuzumab Dose) (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ).

6969884-7 | T-lymphocyte Count Decreased
on Aug 17, 2010 Female patient from UNITED STATES , 74 years of age, weighting 174.2 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath (View Usage). Patient had the following side effects: t-lymphocyte count decreased. Campath dosage: .

6968190-4 | Hepatic Failure, Hepatitis B
on Aug 31, 2010 Male patient from KOREA, REPUBLIC OF , 40 years of age, was diagnosed with infection prophylaxis and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: hepatic failure, hepatitis b (What is hepatitis b?). Campath dosage: Total Daily Dose: 3 Mg. During the same period patient was treated with CISPLATIN (Total Daily Dose: 100 Mg/m2) (View Cisplatin Review and Cisplatin Label ), CYTARABINE (Total Daily Dose: 4000 Mg/m2) (View Cytarabine Review and Cytarabine Label ), DEXAMETHASONE (Total Daily Dose: 40 Mg) (View Dexamethasone Review and Dexamethasone Label ), ACETAMINOPHEN (Before Each Alemtuzumab Dose) (View Acetaminophen Review and Acetaminophen Label ), CHLORPHENIRAMINE MALEATE (Before Each Alemtuzumab Dose) (View Chlorpheniramine Maleate Review and Chlorpheniramine Maleate Label ), VALACYCLOVIR (Three Times A Week, Starting On Day 8 Of The Study) (View Valacyclovir Review and Valacyclovir Label ).

6962491-1 | Atrioventricular Block
Patient was taking Campath (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block on Aug 13, 2010 from UNITED STATES Additional patient health information: Male patient , 40 years of age, weighting 202.8 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), OXYCODONE HCL AND ACETAMINOPHEN (View Oxycodone Hcl And Acetaminophen Review and Oxycodone Hcl And Acetaminophen Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), TREXIMET (View Treximet Review and Treximet Label ).

6944685-4 | Renal Failure
Adverse event was reported on Aug 20, 2010 by a Male patient taking Campath (View Usage) (Dosage: ) was diagnosed with t-cell chronic lymphocytic leukaemia, antiviral prophylaxis and. Location: UNITED STATES , 59 years of age, Patient had the following side effects: renal failure.

6944640-4 | Atrioventricular Block
on Aug 13, 2010 Male patient from UNITED STATES , 40 years of age, weighting 202.8 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: atrioventricular block. Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), OXYCODONE HCL AND ACETAMINOPHEN (View Oxycodone Hcl And Acetaminophen Review and Oxycodone Hcl And Acetaminophen Label ), VITAMIN B COMPLEX CAP (View Vitamin B Complex Cap Review and Vitamin B Complex Cap Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), TREXIMET (View Treximet Review and Treximet Label ).

6942233-6 | Cholecystitis, Renal Failure, Septic Shock
on Aug 19, 2010 Female patient from FRANCE , 62 years of age, was diagnosed with chronic lymphocytic leukaemia recurrent and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: cholecystitis, renal failure, septic shock. Campath dosage: .

6940060-7 | Injection Site Reaction
Patient was taking Campath (View Usage). Patient had the following side effects: injection site reaction on Aug 23, 2010 from UNITED STATES Additional patient health information: Male patient , 83 years of age, was diagnosed with aplastic anaemia and. Campath dosage: Total Daily Dose: 3 Mg.

6940052-8 | Cholecystitis, Renal Failure, Septic Shock
Adverse event was reported on Aug 19, 2010 by a Female patient taking Campath (View Usage) (Dosage: ) was diagnosed with chronic lymphocytic leukaemia recurrent and. Location: FRANCE , 62 years of age, After Campath was administered, patient had the following side effects: cholecystitis, renal failure, septic shock.

6938170-3 | Renal Failure
on Aug 18, 2010 Female patient from UNITED STATES , 45 years of age, was diagnosed with acute myeloid leukaemia and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: renal failure. Campath dosage: Total Daily Dose: 20 Mg. During the same period patient was treated with CLOFARABINE (View Clofarabine Review and Clofarabine Label ), MELPHALAN (View Melphalan Review and Melphalan Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ).

6929714-6 | Anxiety, Chest Pain, Cytomegalovirus Infection, Heart Rate Increased, Hepatic Enzyme Increased, Hepatitis C, Platelet Count Decreased, Splenomegaly, Viral Load Increased
on Aug 09, 2010 Female patient from UNITED STATES , 46 years of age, weighting 194.0 lb, was diagnosed with renal transplant and was treated with Campath (View Usage). Patient had the following side effects: anxiety (What is anxiety?), chest pain (What is chest pain?), cytomegalovirus infection (What is cytomegalovirus infection?), heart rate increased, hepatic enzyme increased, hepatitis c (What is hepatitis c?), platelet count decreased, splenomegaly, viral load increased. Campath dosage: 2 Doses Given: During Kidney Transplant And Again On Day +1.

6929534-2 | Platelet Count Decreased, Pyrexia
Patient was taking Campath (View Usage). After Campath was administered, patient had the following side effects: platelet count decreased, pyrexia on Aug 03, 2010 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with chronic lymphocytic leukaemia and. Campath dosage: As Used: 3 Mg.

6929532-9 | Cerebellar Ataxia, Cerebellar Syndrome, Clostridium Difficile Colitis, Cytomegalovirus Infection, Dysarthria, Enterococcal Sepsis, Neurotoxicity, Pancreatitis Acute, Pneumocystis Jiroveci Pneumonia
Adverse event was reported on Jul 23, 2010 by a Male patient taking Campath (View Usage) (Dosage: 2 Cycles C-chop, On Day 1 Every 3 Weeks) . Location: ITALY , 55 years of age, Patient experienced the following unwanted or unexpected effects: cerebellar ataxia, cerebellar syndrome, clostridium difficile colitis, cytomegalovirus infection (What is cytomegalovirus infection?), dysarthria, enterococcal sepsis, neurotoxicity, pancreatitis acute, pneumocystis jiroveci pneumonia. During the same period patient was treated with PREDNISONE (Days 1-5 Per C-chop Cycle Every 3 Weeks) (View Prednisone Review and Prednisone Label ), DOXORUBICIN HCL (2 C-chop Cycles, On Day 1 Every 3 Weeks) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (2 C-chop Cycles, On Day 1 Every 3 Weeks) (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (2 C-chop Cycles, On Day 1 Every 3 Weeks) (View Cyclophosphamide Review and Cyclophosphamide Label ), METHOTREXATE (2 Applications Every 3 Weeks) (View Methotrexate Review and Methotrexate Label ), ARA C (2 Applications Every 3 Weeks) (View Ara-c Review and Ara-c Label ). Patient was hospitalized.

6929528-7 | Atrial Fibrillation, Injection Site Reaction
on Aug 03, 2010 Male patient from UNITED STATES , 83 years of age, was diagnosed with aplastic anaemia and was treated with Campath (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), injection site reaction. Campath dosage: Total Daily Dose: 3 Mg.

6915952-5 | Platelet Count Decreased, Pyrexia
on Jul 28, 2010 Female patient from UNITED STATES , 55 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: platelet count decreased, pyrexia. Campath dosage: As Used: 3 Mg.

6915873-8 | Adrenal Insufficiency, Castleman's Disease
Patient was taking Campath (View Usage). Patient experienced the following unwanted or unexpected effects: adrenal insufficiency, castleman's disease on Jul 21, 2010 from UNITED STATES Additional patient health information: Female patient , 29 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), prophylaxis, hypothyroidism, asthma (What is asthma?), cytokine release syndrome and. Campath dosage: . During the same period patient was treated with SM3 (Cycle One Day 1 Of Cycle 1) (View Sm3 Review and Sm3 Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), TERBUTALINE SULFATE (250 Mg / Actuation Inhaler, 1 To 2 Puffs) (View Terbutaline Sulfate Review and Terbutaline Sulfate Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6910732-9 | Cerebellar Ataxia, Cerebellar Syndrome, Clostridium Difficile Colitis, Cytomegalovirus Infection, Dysarthria, Enterococcal Sepsis, Neurotoxicity, Pancreatitis Acute, Pneumocystis Jiroveci Pneumonia
Adverse event was reported on Jul 23, 2010 by a Male patient taking Campath (View Usage) (Dosage: 2 Cycles C-chop, On Day 1 Every 3 Weeks) . Location: ITALY , 55 years of age, Patient had the following side effects: cerebellar ataxia, cerebellar syndrome, clostridium difficile colitis, cytomegalovirus infection (What is cytomegalovirus infection?), dysarthria, enterococcal sepsis, neurotoxicity, pancreatitis acute, pneumocystis jiroveci pneumonia. During the same period patient was treated with PREDNISONE (Days 1-5 Per C-chop Cycle Every 3 Weeks) (View Prednisone Review and Prednisone Label ), DOXORUBICIN HCL (2 C-chop Cycles, On Day 1 Every 3 Weeks) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (2 C-chop Cycles, On Day 1 Every 3 Weeks) (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (2 C-chop Cycles, On Day 1 Every 3 Weeks) (View Cyclophosphamide Review and Cyclophosphamide Label ), METHOTREXATE (2 Applications Every 3 Weeks) (View Methotrexate Review and Methotrexate Label ), ARA C (2 Applications Every 3 Weeks) (View Ara-c Review and Ara-c Label ). Patient was hospitalized.

6908027-2 | Adrenal Insufficiency, Castleman's Disease
on Jul 21, 2010 Female patient from UNITED STATES , 29 years of age, was diagnosed with multiple sclerosis (What is multiple sclerosis?), prophylaxis, hypothyroidism, asthma (What is asthma?), cytokine release syndrome and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: adrenal insufficiency, castleman's disease. Campath dosage: . During the same period patient was treated with SM3 (Cycle One Day 1 Of Cycle 1) (View Sm3 Review and Sm3 Label ), LEVOTHYROXINE (View Levothyroxine Review and Levothyroxine Label ), TERBUTALINE SULFATE (250 Mg / Actuation Inhaler, 1 To 2 Puffs) (View Terbutaline Sulfate Review and Terbutaline Sulfate Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6883814-8 | Pneumonitis, Pulmonary Oedema
on Jul 14, 2010 Male patient from UNITED STATES , 22 years of age, weighting 125.7 lb, was diagnosed with renal transplant, blood pressure systolic decreased and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonitis, pulmonary oedema. Campath dosage: 2 Hours Infusion Time. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), DIPHENHYDRAMINE (View Diphenhydramine Review and Diphenhydramine Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), DOPAMINE HCL (3 Mcg/kg/min) (View Dopamine Hcl Review and Dopamine Hcl Label ).

6882462-3 | Cough, Fatigue, Hypotension, Multi-organ Failure, Pancytopenia, Pneumonia, Pseudomonas Test Positive, Sepsis
Patient was taking Campath (View Usage). Patient had the following side effects: cough, fatigue, hypotension, multi-organ failure, pancytopenia, pneumonia (What is pneumonia?), pseudomonas test positive, sepsis (What is sepsis?) on Jul 28, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 156.5 lb, . Campath dosage: 30 Mg. Patient was hospitalized.

6878890-2 | Atrioventricular Block
Adverse event was reported on Jul 13, 2010 by a Male patient taking Campath (View Usage) (Dosage: Total Daily Dose: 12 Mg) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 40 years of age, weighting 202.8 lb, After Campath was administered, patient had the following side effects: atrioventricular block. During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

6868963-2 | Cough, Fatigue, Hypotension, Pancytopenia, Pneumonia, Pseudomonas Test Positive, Sepsis
on Jul 22, 2010 Male patient from UNITED STATES , weighting 156.5 lb, was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: cough, fatigue, hypotension, pancytopenia, pneumonia (What is pneumonia?), pseudomonas test positive, sepsis (What is sepsis?). Campath dosage: 30 Mg. Patient was hospitalized.

6860215-X | Hypotension, Pancytopenia, Pneumonia, Pseudomonas Test Positive, Sepsis
on Jul 19, 2010 Male patient from UNITED STATES , weighting 156.5 lb, was treated with Campath (View Usage). Patient had the following side effects: hypotension, pancytopenia, pneumonia (What is pneumonia?), pseudomonas test positive, sepsis (What is sepsis?). Campath dosage: 30 Mg. Patient was hospitalized.

6856627-0 | Acute Prerenal Failure, Ascites, Gravitational Oedema, Jugular Vein Distension, Oedema Peripheral, Pericardial Effusion, Pericarditis Mycoplasmal, Pleural Effusion, Pseudomonas Infection
Patient was taking Campath (View Usage). After Campath was administered, patient had the following side effects: acute prerenal failure, ascites, gravitational oedema, jugular vein distension, oedema peripheral, pericardial effusion, pericarditis mycoplasmal, pleural effusion, pseudomonas infection on Jun 02, 2010 from UNITED STATES Additional patient health information: Male patient , 64 years of age, was diagnosed with lung transplant (What is lung transplant?), antibiotic prophylaxis and. Campath dosage: Intraoperatively. During the same period patient was treated with TACROLIMUS (Postoperatively) (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (Postoperatively) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (Postoperatively) (View Prednisone Review and Prednisone Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), VALGANCICLOVIR (View Valganciclovir Review and Valganciclovir Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ). Patient was hospitalized.

6856610-5 | Agranulocytosis, Autoimmune Thyroiditis, Basedow's Disease, Thyrotoxic Crisis
Adverse event was reported on Jul 06, 2010 by a Female patient taking Campath (View Usage) (Dosage: Total Daily Dose: 12 Mg) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 34 years of age, weighting 189.6 lb, Patient experienced the following unwanted or unexpected effects: agranulocytosis, autoimmune thyroiditis, basedow's disease, thyrotoxic crisis. During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ZOFRAN (View Zofran Review and Zofran Label ), ADVIL LIQUI GELS (View Advil Liqui-gels Review and Advil Liqui-gels Label ), NUVIGIL (View Nuvigil Review and Nuvigil Label ), VALTREX (Total Daily Dose: 1000 Mg) (View Valtrex Review and Valtrex Label ). Patient was hospitalized.

6847372-6 | Acute Prerenal Failure, Ascites, Gravitational Oedema, Jugular Vein Distension, Oedema Peripheral, Pericardial Effusion, Pericarditis Mycoplasmal, Pleural Effusion, Pseudomonas Infection
on Jul 02, 2010 Male patient from UNITED STATES , 64 years of age, was diagnosed with lung transplant (What is lung transplant?), antibiotic prophylaxis and was treated with Campath (View Usage). Patient had the following side effects: acute prerenal failure, ascites, gravitational oedema, jugular vein distension, oedema peripheral, pericardial effusion, pericarditis mycoplasmal, pleural effusion, pseudomonas infection. Campath dosage: Intraoperatively. During the same period patient was treated with TACROLIMUS (Postoperatively) (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (Postoperatively) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE TAB (Postoperatively) (View Prednisone Tab Review and Prednisone Tab Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), VALGANCICLOVIR (View Valganciclovir Review and Valganciclovir Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ). Patient was hospitalized.

6835277-6 | Atrioventricular Block
on Jun 29, 2010 Male patient from UNITED STATES , 40 years of age, weighting 202.8 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: atrioventricular block. Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

6835253-3 | Bronchopulmonary Aspergillosis, Cerebral Aspergillosis, Febrile Neutropenia, Haemorrhagic Transformation Stroke, Meningitis, Respiratory Failure, Systemic Mycosis
Patient was taking Campath (View Usage). Patient experienced the following unwanted or unexpected effects: bronchopulmonary aspergillosis, cerebral aspergillosis, febrile neutropenia, haemorrhagic transformation stroke, meningitis (What is meningitis?), respiratory failure, systemic mycosis on Jun 18, 2010 from GERMANY Additional patient health information: Female patient , 76 years of age, weighting 110.2 lb, was diagnosed with chronic lymphocytic leukaemia, prophylaxis, neutropenia, bronchopulmonary aspergillosis, humoral immune defect and. Campath dosage: Dose Escalation. During the same period patient was treated with FORTECORTIN (As Used: 40 Mg) (View Fortecortin Review and Fortecortin Label ), NEULASTA (On Days 1 And 15 Per Cycle, Every 4 Weeks (per Protocol)) (View Neulasta Review and Neulasta Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), VFEND (Total Daily Dose: 400 Mg) (View Vfend Review and Vfend Label ), FLEBOGAMMA (HUMAN IGG) (View Flebogamma (human Igg) Review and Flebogamma (human Igg) Label ). Patient was hospitalized.

6830902-8 | Bronchopulmonary Aspergillosis, Cerebral Aspergillosis, Febrile Neutropenia, Haemorrhagic Transformation Stroke, Meningitis, Respiratory Failure, Systemic Mycosis
Adverse event was reported on Jun 18, 2010 by a Female patient taking Campath (View Usage) (Dosage: Dose Escalation) was diagnosed with chronic lymphocytic leukaemia, prophylaxis, neutropenia, bronchopulmonary aspergillosis, humoral immune defect and. Location: GERMANY , 76 years of age, weighting 110.2 lb, Patient had the following side effects: bronchopulmonary aspergillosis, cerebral aspergillosis, febrile neutropenia, haemorrhagic transformation stroke, meningitis (What is meningitis?), respiratory failure, systemic mycosis. During the same period patient was treated with FORTECORTIN (As Used: 40 Mg) (View Fortecortin Review and Fortecortin Label ), NEULASTA (On Days 1 And 15 Per Cycle, Every 4 Weeks (per Protocol)) (View Neulasta Review and Neulasta Label ), RED BLOOD CELLS (View Red Blood Cells Review and Red Blood Cells Label ), VFEND (Total Daily Dose: 400 Mg) (View Vfend Review and Vfend Label ), FLEBOGAMMA (HUMAN IGG) (View Flebogamma (human Igg) Review and Flebogamma (human Igg) Label ). Patient was hospitalized.

6822064-8 | Basedow's Disease, Neutropenia, Thyrotoxic Crisis
on Jun 01, 2010 Female patient from UNITED STATES , 34 years of age, weighting 189.6 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: basedow's disease, neutropenia, thyrotoxic crisis. Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ZOFRAN (View Zofran Review and Zofran Label ), ADVIL LIQUI GELS (View Advil Liqui-gels Review and Advil Liqui-gels Label ), NUVIGIL (View Nuvigil Review and Nuvigil Label ), VALTREX (Total Daily Dose: 1000 Mg) (View Valtrex Review and Valtrex Label ). Patient was hospitalized.

6816611-X | Chest Pain
on Jun 24, 2010 Male patient from UNITED STATES , 40 years of age, weighting 202.8 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?). Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

6813937-0 | Basedow's Disease, Neutropenia, Thyrotoxic Crisis
Patient was taking Campath (View Usage). Patient had the following side effects: basedow's disease, neutropenia, thyrotoxic crisis on Jun 01, 2010 from UNITED STATES Additional patient health information: Female patient , 34 years of age, weighting 189.6 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ZOFRAN (View Zofran Review and Zofran Label ), ADVIL LIQUI GELS (View Advil Liqui-gels Review and Advil Liqui-gels Label ), NUVIGIL (View Nuvigil Review and Nuvigil Label ), VALTREX (Total Daily Dose: 1000 Mg) (View Valtrex Review and Valtrex Label ). Patient was hospitalized.

6800738-2 | Nephrolithiasis
Adverse event was reported on Jun 16, 2010 by a Male patient taking Campath (View Usage) (Dosage: Total Daily Dose: 12 Mg) was diagnosed with multiple sclerosis (What is multiple sclerosis?) and. Location: UNITED STATES , 28 years of age, weighting 174.2 lb, After Campath was administered, patient had the following side effects: nephrolithiasis. During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6785596-7 | Thyroid Cancer
on Jun 08, 2010 Female patient from UNITED STATES , 34 years of age, weighting 202.8 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: thyroid cancer (What is thyroid cancer?). Campath dosage: . During the same period patient was treated with REBIF (Titrated Up To 44 Mcg) (View Rebif Review and Rebif Label ), METHIMAZOLE (View Methimazole Review and Methimazole Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), IODINE (131 I) (View Iodine (131 I) Review and Iodine (131 I) Label ). Patient was hospitalized.

6782962-0 | Back Pain, Nephrolithiasis
on Jun 08, 2010 Male patient from UNITED STATES , 28 years of age, weighting 174.2 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Campath (View Usage). Patient had the following side effects: back pain (What is back pain?), nephrolithiasis. Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with PERCOCET (Every 4-6 Hours) (View Percocet Review and Percocet Label ), FLOMAX (View Flomax Review and Flomax Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

6774213-8 | Sclerosing Encapsulating Peritonitis, Tubulointerstitial Nephritis
Patient was taking Campath (View Usage). After Campath was administered, patient had the following side effects: sclerosing encapsulating peritonitis, tubulointerstitial nephritis on Jun 08, 2010 from AUSTRIA Additional patient health information: Female patient , 55 years of age, was diagnosed with renal transplant, urinary tract inflammation and. Campath dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), SIROLIMUS (View Sirolimus Review and Sirolimus Label ).

6770841-4 | Cellulitis, Pyrexia
Adverse event was reported on Apr 26, 2010 by a Male patient taking Campath (View Usage) (Dosage: 30mg, Qd, Iv) was diagnosed with renal transplant and. Location: UNITED STATES , weighting 190.5 lb, Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?), pyrexia. Patient was hospitalized.

6769216-3 | Lung Infection Pseudomonal, Pyrexia
on May 31, 2010 Female patient from ITALY , 34 years of age, was treated with Campath (View Usage). Patient had the following side effects: lung infection pseudomonal, pyrexia. Campath dosage: Day 1. During the same period patient was treated with DOXORUBICIN HCL (Day 1) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINCRISTINE (Day 1, (maximum 2.0 Mg)) (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (Day 1) (View Cyclophosphamide Review and Cyclophosphamide Label ), PREDNISONE (Days 1-5) (View Prednisone Review and Prednisone Label ), METHOTREXATE (Day 1) (View Methotrexate Review and Methotrexate Label ), ARA C (Day 1) (View Ara-c Review and Ara-c Label ), DEXAMETHASONE (Day 1) (View Dexamethasone Review and Dexamethasone Label ), DOLESTIN (View Dolestin Review and Dolestin Label ). Patient was hospitalized.

6768253-2 | Bradycardia, Bronchiolitis, Cardio-respiratory Arrest, Chest Pain, Confusional State, Dyspnoea, Fall, Hypotension, Traumatic Lung Injury
on Jun 07, 2010 Female patient from UNITED STATES , 57 years of age, weighting 156.5 lb, was diagnosed with acute leukaemia, myocardial ischaemia and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: bradycardia, bronchiolitis, cardio-respiratory arrest, chest pain (What is chest pain?), confusional state, dyspnoea, fall (What is fall?), hypotension, traumatic lung injury. Campath dosage: . During the same period patient was treated with CLOFARABINE (View Clofarabine Review and Clofarabine Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ).

6768252-0 | Acute Myeloid Leukaemia Recurrent, Ascites, Hepatosplenomegaly, Multi-organ Failure, Pseudomonal Sepsis, Renal Failure, Septic Shock
Patient was taking Campath (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia recurrent, ascites, hepatosplenomegaly, multi-organ failure, pseudomonal sepsis, renal failure, septic shock on Jun 07, 2010 from UNITED STATES Additional patient health information: Male patient , 25 years of age, weighting 172.0 lb, was diagnosed with bone marrow conditioning regimen and. Campath dosage: 20mg/day X5 Days. During the same period patient was treated with CLOFARABINE (Total Daily Dose: 38 Mg Unit Dose: 20 Mg/m2) (View Clofarabine Review and Clofarabine Label ), MELPHALAN HYDROCHLORIDE (Total Daily Dose: 190 Mg) (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), PROGRAF (View Prograf Review and Prograf Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), LEVOPRED (View Levopred Review and Levopred Label ), VASOPRESSIN (View Vasopressin Review and Vasopressin Label ), DAPTOMYCIN (View Daptomycin Review and Daptomycin Label ).

6768251-9 | Abscess Jaw, Cellulitis, Oral Herpes
Adverse event was reported on May 26, 2010 by a Female patient taking Campath (View Usage) (Dosage: Total Daily Dose: 12 Mg) was diagnosed with multiple sclerosis (What is multiple sclerosis?), prophylaxis and. Location: UNITED STATES , 39 years of age, weighting 207.2 lb, Patient had the following side effects: abscess jaw, cellulitis (What is cellulitis?), oral herpes. During the same period patient was treated with ACYCLOVIR (Total Daily Dose: 400 Mg) (View Acyclovir Review and Acyclovir Label ), REBIF (Total Daily Dose: 44 ?g) (View Rebif Review and Rebif Label ). Patient was hospitalized.

6767304-9 | Basedow's Disease, Neutropenia, Thyrotoxic Crisis
on Jun 01, 2010 Female patient from UNITED STATES , 34 years of age, weighting 189.6 lb, was diagnosed with multiple sclerosis (What is multiple sclerosis?) and was treated with Campath (View Usage). After Campath was administered, patient had the following side effects: basedow's disease, neutropenia, thyrotoxic crisis. Campath dosage: Total Daily Dose: 12 Mg. During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ZOFRAN (View Zofran Review and Zofran Label ), ADVIL LIQUI GELS (View Advil Liqui-gels Review and Advil Liqui-gels Label ), NUVIGIL (View Nuvigil Review and Nuvigil Label ), VALTREX (Total Daily Dose: 1000 Mg) (View Valtrex Review and Valtrex Label ). Patient was hospitalized.

6767267-6 | Bradycardia, Bronchiolitis, Cardio-respiratory Arrest, Chest Pain, Confusional State, Dyspnoea, Fall, Hypotension, Traumatic Lung Injury
on Jun 07, 2010 Female patient from UNITED STATES , 57 years of age, weighting 156.5 lb, was diagnosed with acute leukaemia, myocardial ischaemia and was treated with Campath (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, bronchiolitis, cardio-respiratory arrest, chest pain (What is chest pain?), confusional state, dyspnoea, fall (What is fall?), hypotension, traumatic lung injury. Campath dosage: . During the same period patient was treated with CLOFARABINE (View Clofarabine Review and Clofarabine Label ), LOPRESSOR (View Lopressor Review and Lopressor Label ).

6766251-6 | Acute Myeloid Leukaemia Recurrent, Hepatosplenomegaly, Multi-organ Failure, Pseudomonal Sepsis, Septic Shock
Patient was taking Campath (View Usage). Patient had the following side effects: acute myeloid leukaemia recurrent, hepatosplenomegaly, multi-organ failure, pseudomonal sepsis, septic shock on Jun 07, 2010 from UNITED STATES Additional patient health information: Male patient , 25 years of age, weighting 172.0 lb, was diagnosed with bone marrow conditioning regimen and. Campath dosage: 20mg/day X5 Days. During the same period patient was treated with CLOFARABINE (Total Daily Dose: 38 Mg Unit Dose: 20 Mg/m2) (View Clofarabine Review and Clofarabine Label ), MELPHALAN HYDROCHLORIDE (Total Daily Dose: 190 Mg) (View Melphalan Hydrochloride Review and Melphalan Hydrochloride Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), PROGRAF (View Prograf Review and Prograf Label ), ZYPREXA (View Zyprexa Review and Zyprexa Label ), LEVOPRED (View Levopred Review and Levopred Label ), VASOPRESSIN (View Vasopressin Review and Vasopressin Label ), DAPTOMYCIN (View Daptomycin Review and Daptomycin Label ).